Filing Flows › Encompass Health (EHC) › Q3 2026
Encompass Health (EHC) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 3, 2026
Encompass Health (EHC) reported revenue of $1.6B for the third quarter 2026 (Q3 2026), +9% from a year earlier and +0.8% from the quarter before. Operating margin was 17.9%, net earnings $150M (9.3% of revenue).
Encompass Health, Q3 2026: revenue $1.6B (+9% year over year), operating margin 17.9%, net earnings $150M, operating cash flow $362M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6B | +0.8% | +9% |
| Operating profit | $288M | -0.1% | +18% |
| Net earnings | $150M | -3% | +18% |
| Operating cash flow | $362M | +28% | +34% |
| Free cash flow | $128M | +105% | +52% |
What changed
Revenue was $1.6B in Q3 2026, up 9% year over year and up 1% from the previous quarter. Medicare was the largest line at 66% of revenue. Medicare added $0.12B year over year (up 13%), 92% of the total change. Other declined 20%.
Operating profit was $0.29B, a 17.9% margin (up 1.4 points year over year). Of the extra revenue versus Q3 2025, 34% reached operating profit, above the 16% margin then. Total costs grew 7% against revenue growth of 9%. Net earnings were $0.15B, up 18% year over year. The effective tax rate was 20.8%.
Operating cash flow was $0.36B (up 34% year over year), 178% of net income including minority interests. Non-cash charges added back $0.10B of depreciation and amortization and $0.01B of share-based compensation. Working capital and other items added $0.05B. Capital expenditures of $0.23B left free cash flow of $0.13B.
Questions
What was Encompass Health's revenue in the third quarter 2026?
Encompass Health (EHC) reported revenue of $1.6B for the third quarter 2026 (Q3 2026), +9% from a year earlier and +0.8% from the quarter before.
Was Encompass Health profitable in the third quarter 2026?
Operating profit was $288M (17.9% of revenue) and net earnings $150M.
Source: Encompass Health 10-Q on SEC EDGAR.